Replies to post #30379 on Marker Therapeutics Inc (MRKR)

[Buckboard]

My wife says I'm wrong a lot but I took this to mean they intend to use it to make the reagents they need in their own quality certified facility rather than obtain them from the sources that have caused the delays.
If not that I hope it's Hostess rather than LD.
"Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that it has executed a lease agreement to establish a cGMP manufacturing facility in Houston, TX, in an area near the George Bush Intercontinental Airport. The facility will allow production according to U.S. Food and Drug Administration (FDA) guidelines and is designed to be scalable using modular processes. The facility is expected to be completed by year-end and operational in 2021.

[floridajim1]

I'd say ( forgive the pun ) you're way Over Due.